All of these results provide the strong supporting evidence that JT003 improves lipid metabolism in NASH mice through increasing of AMPK and PPARα as well as the PI3K-Akt-PPARγ signal activity. Here, PPARA is linked to metabolic dysfunction-associated steatohepatitis.